The lack of significant correlation between IGF2BPs and overall survival in ESCC patients may be related to the small sample size, and it can be speculated from the positive results in other tumors that IGF2BP2 is a potential prognostic marker associated with ESCC. The gene discussed is IGF2BP2; the disease is esophageal squamous cell carcinoma.